This marks a significant turning point for Bugatti as they embrace electrification, a move usually seen in production cars today.
Researchers at the US Southwest Research Institute (SwRI) have developed camera-based autonomous driving tools that can work without deploying technologies like LIDAR and RADAR.
The technology can potentially deliver stealth capabilities for the military while finding applications in space and agriculture.
Modern autonomous driving solutions rely extensively on light detection and ranging (LIDAR) sensors to visualize objects around the vehicle. A software solution then identifies the objects nearby and helps the vehicle’s computer decide whether to halt or slow down.
With their lightweight, flexible design, printed solar cells can be deployed in previously unimaginable ways.
China is trusting AI system for high-speed railway operations capable of accurately predicting faults and issuing warnings ahead of problems.
Artificial intelligence has delivered a major win for pathologists and researchers in the fight for improved cancer treatments and diagnoses.
“Devin,” the world’s first-ever AI software developer, is set to rock the software developer industry forever:
Meet ‘Devin,’ the world’s first-ever AI software engineer which is set to change the industry forever. Are you excited or scared yet?
A study led by Daniel Spratt, M.D., Vincent K. Smith Chair in Radiation Oncology at University Hospitals Seidman Cancer Center demonstrates the safety and efficacy of a novel oral hormone therapy, relugolix, in conjunction with radiation therapy for treating men with localized and advanced prostate cancer. This work is published in JAMA Oncology.
Only 3% to 5% of people who are diagnosed with this type of brain tumor will be alive three years later. On average, patients live about 14 months after diagnosis.
Now, an experimental therapy that reprograms a person’s own immune cells to attack these tumors is showing some exciting promise.
Three studies published within the past week have reported dramatic results with a therapy called CAR-T delivered directly to the brain. In some cases, tumors have seemingly melted away on brain scans by the next day.
After a decade of investigation, Melbourne researchers have made a discovery that will lead to new ways to treat an aggressive blood cancer ].
A study of more than 21,000 average risk patients at 186 sites across the U.S., led by Regenstrief Institute and Indiana University School of Medicine research scientist Thomas Imperiale, M.D., has found that the next-generation multi-target stool DNA colorectal cancer screening test detects 94% of colorectal cancers. This test has the best performance for detection of both colorectal cancer and advanced precancerous polyps of any noninvasive colorectal cancer screening test.
The study results are published in the New England Journal of Medicine.
“We found that the next-generation stool DNA test had a good balance of sensitivity—detecting disease—and specificity—low false positive results. Compared to the fecal immunochemical test (FIT), the next gen test had superior sensitivity for both colorectal cancer and advanced pre-cancerous polys, especially the subgroup of advanced polyps containing high grade dysplasia,” said Dr. Imperiale, first author of the study.